Guyer Charles Greg 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Guyer Charles Greg
EVP, Chief Technical Officer
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2025-03-17+30,880→ 30,880 totalExercise: $71.55From: 2026-03-17Exp: 2035-03-16→ Common Stock (30,880 underlying) - Award
Common Stock
2025-03-17+13,310→ 80,838 total - Tax Payment
Common Stock
2025-03-14$69.44/sh−20,127$1,397,619→ 67,528 total
Footnotes (2)
- [F1]Restricted stock units granted March 17, 2025. Price not applicable.
- [F2]Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.